The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2015

Filed:

May. 23, 2013
Applicants:

Takuya Tsunoda, Kanagawa, JP;

Ryuji Ohsawa, Kanagawa, JP;

Sachiko Yoshimura, Kanagawa, JP;

Tomohisa Watanabe, Kanagawa, JP;

Inventors:

Takuya Tsunoda, Kanagawa, JP;

Ryuji Ohsawa, Kanagawa, JP;

Sachiko Yoshimura, Kanagawa, JP;

Tomohisa Watanabe, Kanagawa, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/04 (2006.01); A61K 38/08 (2006.01); C07K 14/47 (2006.01); A61K 39/00 (2006.01); A61K 38/17 (2006.01); C12N 5/0783 (2010.01); C12N 5/0784 (2010.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4748 (2013.01); A61K 38/1764 (2013.01); A61K 39/0011 (2013.01); C07K 14/47 (2013.01); C12N 5/0638 (2013.01); C12N 5/0639 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention provides peptides containing the amino acid sequence of SEQ ID NOs: 1, 2, 3, 4, 16, 17, 30, 31, 34, 36, 37, 40, 41, 45, 49, 55, 57 and 61, as well as peptides containing the above-mentioned amino acid sequences in which 1, 2, or several amino acid(s) are substituted, deleted, inserted or added, but still have cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing tumors, which drugs containing these peptides. The peptides of the present invention can also be used as vaccines.


Find Patent Forward Citations

Loading…